BOCA RATON, Fla., July 31, 2017 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leader in the collection of Source Plasma, is pleased to announce the relocation of its Pembroke Pines Plasma Center to 6837 Taft Street, Hollywood FL., 33024. The 16,000 square foot state-of-the-art facility officially opened its doors for business on Sunday, July 30, 2017.
"The relocation of this facility represents our goal to continually enhance our donors experience and remain steadfast on our mission to secure a quality supply of the raw materials needed to help the thousands of patients that rely on plasma based therapies," said Ileana Carlisle, BPC's Chief Executive Officer.
The plasma collected at Biotest Plasma Centers is used to manufacture critical care therapies that treat life threatening disorders in a variety of therapeutic areas.
The Company anticipates that this newly relocated facility will expand the Center's workforce to over 50 employees and currently has employment opportunities available for medical personnel and phlebotomists.
In addition to supporting the local economy through employment opportunities, the Plasma Center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material used to manufacture plasma derived therapies but are also compensated for their plasma donations.
About Biotest Pharmaceuticals Corporation Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company owns and manages twenty two plasmapheresis centers across the United States. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies. Biotest Pharmaceuticals' team of over 900 employees is part of Biotest AG's global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.
Advertisement
"The relocation of this facility represents our goal to continually enhance our donors experience and remain steadfast on our mission to secure a quality supply of the raw materials needed to help the thousands of patients that rely on plasma based therapies," said Ileana Carlisle, BPC's Chief Executive Officer.
Advertisement
The plasma collected at Biotest Plasma Centers is used to manufacture critical care therapies that treat life threatening disorders in a variety of therapeutic areas.
The Company anticipates that this newly relocated facility will expand the Center's workforce to over 50 employees and currently has employment opportunities available for medical personnel and phlebotomists.
In addition to supporting the local economy through employment opportunities, the Plasma Center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material used to manufacture plasma derived therapies but are also compensated for their plasma donations.
About Biotest Pharmaceuticals Corporation Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company owns and manages twenty two plasmapheresis centers across the United States. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies. Biotest Pharmaceuticals' team of over 900 employees is part of Biotest AG's global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.
View original content:http://www.prnewswire.com/news-releases/biotest-pharmaceuticals-corporation-announces-the-relocation-of-its-plasma-collection-facility-to-hollywood-florida-300496738.html
SOURCE Biotest Pharmaceuticals Corporation
